EIF2α phosphorylation is induced by ICD‐stimulatory chemotherapeutics and correlates with CALR exposure, increased tumor infiltration by activated DC and T lymphocytes, as well as with favorable prognosis (Rae‐Grant et al, 1991; Panaretakis et al, 2009; Fucikova et al, 2016a,b; Bezu et al, 2018; Giglio et al, 2018). The gene discussed is EIF2A; the disease is neoplasm.